Catriona Froggatt

Chris O’Brien Lifehouse

Papers

2

Total Citations

12

H-Index

2

About

Catriona Froggatt is a surgical oncologist whose work is reshaping the treatment of oropharyngeal cancer through the precision of transoral robotic surgery (TORS). Her research focuses on two critical frontiers: optimizing reconstructive outcomes and safely de-escalating adjuvant therapy. In her highly cited 2020 paper on transoral robotic free flap inset, she pioneered a minimally invasive technique for reconstructing complex defects after tumor resection, demonstrating how robotic assistance can improve functional recovery while maintaining oncologic safety. Her 2022 cohort study, with 5 citations, tackled the pressing question of whether primary site adjuvant radiotherapy can be avoided after TORS. By analyzing disease control and swallowing outcomes, she provided compelling evidence that select patients may safely forgo post-operative radiation, sparing them from its debilitating side effects. This work directly challenges conventional treatment paradigms, offering patients a path to better quality of life without compromising cancer control. Froggatt’s contributions are particularly impactful in the era of HPV-related oropharyngeal cancers, where de-escalation strategies are paramount. Her research bridges surgical innovation and patient-centered outcomes, establishing her as a rising authority in head and neck oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
12
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Transoral robotic free flap inset in oropharyngeal cancer
7 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Chris O’Brien Lifehouse

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago